Zoetis was granted a conditional license for its avian influenza vaccine for use in chickens. It's a step closer to fighting the bird flu outbreaks that continue to devastate flocks.
StockStory.org on MSN5h
2 Healthcare Stocks with Big Upside and 1 to SkipHealthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But ...
VMX 2025, the world’s largest veterinary conference, drew about 30,000 attendees from 86 countries to see the latest treatments and technologies.
In the past three years, the U.S. Department of Agriculture (USDA) says about 150 million birds died across the country due ...
From Feb. 1 to April 30, 2025, customers can direct a portion of sales from eligible Zoetis to their local National FFA Organization chapters.
All 80 sites on Long Island, New York City and Westchester County were cleaned and disinfected, according to state officials.
The U.S. Department of Agriculture (USDA) has granted conditional approval for a new bird flu vaccine for poultry.Thi ...
The New Jersey-based drugmaker secured a conditional license to protect chickens with its H5N2 subtype vaccine.
Bird flu has infected more than 150 million birds and close to 70 people in the U.S. since it began ...
In a report released today, Michael Ryskin from Bank of America Securities maintained a Buy rating on Zoetis (ZTS – Research Report). The ...
Zoetis received a USDA conditional license for its H5N2 avian flu vaccine for chickens, marking a step in addressing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results